# Giant Microorganisms

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/giant-microorganisms

- Industry: Materials
- Headquarters: Guangzhou, China
- Latest round: Series A (Nov 26, 2025)
- Investors on record: 1

## About

Founded in 2024 and based in Guangzhou, China, Guangzhou Giant Microbial Technology Co., Ltd., Giant Microorganisms, is a biotech company that focuses on the research and development of hyaluronic acid (HA) and oligosaccharides. In November 2024, the firm closed a venture funding. In November 2025, Giant Microorganisms closed a Series A+ funding from new investor JC Capital.

The company's main products include ultra-low molecular weight hyaluronic acid, acid chondroitin oligosaccharides, fucose and electrostatic nano-multi-spinning membranes. Its products are used in the fields of beauty and daily chemicals, food and health products, medical beauty and medicine. 

The company’s revenue is generated by providing hyaluronic acid and oligosaccharides and other related products.

The Series A+ funding raised in November 2025 will be used for technology research and development, capacity expansion, and market development, further consolidating its leading position in the field of green biomanufacturing.

## Funding rounds

- Series A, Nov 26, 2025 — JC Capital

## Investors

- JC Capital (https://capitalatlas.ai/funds/jc-capital) — Series A